HALO logo
halo search icon
Royalty Pharma Plc Class A

US$53.06

Price Change Indicator
0.65 (1.24%)
Royalty Pharma Plc Class A
RPRX · NAS

Royalty Pharma Plc Class A

Start Trading RPRX for Free

US$53.06

Price Arrow0.65 (1.24%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Dividend GrowthHALO GARPHALO GrowthHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Royalty Pharma Plc Class A Overview

RPRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Strong

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

About RPRX

icon
icon

Telephone

1.212.883.0200

icon

Address

33rd floor, 110 East 59th Street, New York, NY 10022

Description

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

RPRX Price Chart

Key Stats

Market Cap

US$23.23B

PE

21.70

EV/EBITDA

21.3

Dividends Overview

DIV Yield

2.3%

Franking

N/A

Ex Dividend Date (est.)

15-May-26

Market Data

52 weeks range

Low 32.15 - 53.47

Trade Value (12mth)

US$38,138,793.00

1 week

-0.83%

1 month

5.92%

YTD

34.87%

1 year

59.64%

All time high

56.50

Key Fundamentals

EPS 3 yr Growth

1734.00%

EBITDA Margin

65.70%

Operating Cashflow

$2,595m

Free Cash Flow Return

18.10%

ROIC

5.40%

Interest Coverage

5.10

Quick Ratio

2.40

Other Data

Shares Outstanding (Fully Diluted)

557m

HALO Sector

Healthcare

Next Company Report Date

16-Feb-27

Next Ex Dividend Date

15-May-26

Next Dividend Pay Date

10-Jun-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

RPRX Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
06 May 26

RPRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.541.921.79locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.531.911.78locklocklock
Growth
 %locklocklocklock2,492.4-24.4-6.4locklocklock
PE
 Xlocklocklocklock11.113.321.7locklocklock
EV/EBITDA
 Xlocklocklocklock17.519.521.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

15-May-26

DIV Yield

2.3%

Franking Level

N/A

DPSg

4.8%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
The current share price of Royalty Pharma Plc Class A (RPRX:NAS) is USD$53.06.
What is the 52-week high share price for Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
The 52-week high share price for Royalty Pharma Plc Class A (RPRX:NAS) is USD$53.47.
What is the 52-week low share price for Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
The 52-week low share price for Royalty Pharma Plc Class A (RPRX:NAS) is USD$32.15.
What is the dividend yield for Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
The current TTM dividend payout for Royalty Pharma Plc Class A (RPRX:NAS) is 2.30.
What was Royalty Pharma Plc Class A (RPRX:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Royalty Pharma Plc Class A (RPRX:NAS) is USD$0.24.
What is the franking level for Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
Royalty Pharma Plc Class A (RPRX:NAS) has a franking level of 0.00%.
In which sector is Royalty Pharma Plc Class A (RPRX:NAS) classified?
Halo FAQ
Royalty Pharma Plc Class A (RPRX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Royalty Pharma Plc Class A (RPRX:NAS)?
Halo FAQ
The current P/E ratio for Royalty Pharma Plc Class A (RPRX:NAS) is 21.70.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial